Pridopidine in Amyotrophic Lateral Sclerosis

Overview of attention for article published in JAMA: Journal of the American Medical Association, February 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 32 news outlets
blogs: 3 blogs
twitter: 10 X users
facebook: 3 Facebook pages

reddit: 1 Redditor
video: 1 YouTube creator
bluesky: 4 Bluesky users
podcasts: 2 podcasts

Readers on

mendeley: 26 Mendeley

So far, Altmetric has seen 35 news stories from 32 outlets.

Prilenia and Ferrer Announce Initiation of the Confirmatory PRECISE-HD Study of Pridopidine in Huntington’s Disease

BioSpace, 07 Jul 2026

9 min read PRECISE-HD (Pridopidine Phase 3 Study to Establish Clinical Impact and Safety in Huntington’s Disease (HD)) is…

News story from Finanz Nachrichten on Tuesday 07 July 2026

Finanz Nachrichten, 07 Jul 2026

Prilenia and Ferrer Announce Initiation of the Confirmatory PRECISE-HD Study of Pridopidine in Huntington’s Disease

Times Argus, 07 Jul 2026

Prilenia Therapeutics B.V.andFerreri today announced initiation of the confirmatory PRECISE-HD study (Pridopidine Phase 3 Study…

Prilenia and Ferrer Announce Initiation of the Confirmatory PRECISE-HD Study of Pridopidine in Huntington’s Disease

Yahoo! Finance USA, 07 Jul 2026

BUSINESS WIRE and Ferreri today announced initiation of the confirmatory PRECISE-HD study (Pridopidine Phase 3 Study to…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 31 additional news stories.